"The ADRIATIC Trial: Consolidation Immunotherapy in Limited-Stage SCLC" takes up the trial that the panel calls the biggest ...

Two new studies led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center provide new insight into how the ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway ...

Olive pollen immunotherapy was linked to improved allergy symptoms and fewer asthma exacerbations, with no severe systemic ...

Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced that three ...

A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the ...

Immorta Bio, Inc., a biotechnology company pioneering therapies targeting fundamental mechanisms of aging, today announced ...

In "Closing the Gap: Underused Consolidation Immunotherapy in Limited-Stage SCLC," our experts confront a stubborn disconnect ...

An early data check showed the shot didn’t delay tumor progression in a form of head and neck cancer, though BioNTech is ...

The study showed OncoPrism-NSCLC significantly predicted overall response and identified the subset of patients with doubled median overall survival i ...

Researchers used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, ...